173
Views
2
CrossRef citations to date
0
Altmetric
Article

Effects of Vitamin D Analogs Alfacalcidol and Calcitriol on Cell Proliferation and Migration of HEC1A Endometrial Adenocarcinoma Cells

, &
Pages 273-281 | Received 18 Jul 2019, Accepted 26 Apr 2020, Published online: 13 May 2020
 

Abstract

Endometrial carcinoma is the most diagnosed among infiltrating tumor of the female genital tract. Vitamin D has antiproliferative and immunomodulatory properties besides its classical effect on calcium and phosphate. We aimed to demonstrate whether alfacalcidol and calcitriol have any effect on proliferation and migration. Endometrial adenocarcinoma HEC1A was used as a cancer cell line. The effect of alfacalcidol (1α-hydroxyvitamin D3) and calcitriol (1α,25-dihydroxyvitamin D3) on proliferation was demonstrated by real-time cell analysis device and migration was shown by a wound healing model. 10−11–10−9M alfacalcidol and calcitriol reduced both proliferation and migration. In contrast, the high concentration of alfacalcidol and calcitriol (10−8–10−6M) increased proliferation and migration. The proliferative effects of alfacalcidol (0–12 h) immediately started earlier than calcitriol (12–48 h). In contrast, the antiproliferative effects of calcitriol (12–24 h) have begun earlier than alfacalcidol (48–60 h). While the high concentrations of alfacalcidol and calcitriol increased the migration relatively earlier (12–24 h), low concentrations decreased the migration at late times (24–48 h). Lower concentrations of vitamin D prevent proliferation and migration in endometrial adenocarcinoma HEC1A cells. In contrast, high concentrations of vitamin D increase proliferation and migration.

Disclosure Statement

The authors declare that they have no conflicts of interest.

Additional information

Funding

This study was supported by the Mersin University Scientific Research Projects Center, grant project number: 2015-TP2-1172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.